Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.75
-0.30 (-1.57%)
At close: Mar 13, 2026, 4:00 PM EDT
18.58
-0.17 (-0.91%)
After-hours: Mar 13, 2026, 7:02 PM EDT

Legend Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,4684,0155,96910,9388,3577,175
Market Cap Growth
-48.52%-32.74%-45.43%30.89%16.46%92.11%
Enterprise Value
2,9333,4335,1049,8357,6956,613
Last Close Price
18.7521.7432.5460.1749.9246.61
PS Ratio
3.373.909.5238.3771.42104.26
PB Ratio
3.464.015.748.7411.239.37
P/TBV Ratio
3.464.015.748.7711.289.43
EV/Sales Ratio
2.853.348.1434.5065.7696.08
Debt / Equity Ratio
0.410.410.340.260.380.16
Net Debt / Equity Ratio
-0.53-0.53-0.74-0.78-1.00-0.99
Net Debt / EBITDA Ratio
4.214.212.621.891.661.97
Net Debt / FCF Ratio
4.154.154.882.373.343.16
Asset Turnover
0.610.610.360.180.100.08
Inventory Turnover
29.4429.4429.9135.3466.27176.58
Quick Ratio
1.881.884.496.773.594.11
Current Ratio
1.961.964.626.923.694.14
Return on Equity (ROE)
-29.06%-29.06%-15.45%-51.94%-59.11%-59.19%
Return on Assets (ROA)
-5.01%-5.01%-10.84%-20.76%-23.37%-26.75%
Return on Invested Capital (ROIC)
-30.46%-37.10%-113.02%-384.74%-9433.71%-770.35%
Return on Capital Employed (ROCE)
-12.40%-12.40%-21.90%-32.40%-44.30%-44.30%
Earnings Yield
-8.56%-7.39%-2.96%-4.74%-5.34%-5.62%
FCF Yield
-3.71%-3.21%-2.65%-3.78%-2.66%-3.35%
Buyback Yield / Dilution
-0.80%-0.80%-3.84%-10.71%-12.91%-19.21%
Updated Mar 10, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q